- Home
- MGRX vs NURO Comparison
MGRX vs NURO Comparison
Compare MGRX & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- NURO
- Stock Information
- Founded
- MGRX 2021
- NURO 1996
- Country
- MGRX United States
- NURO United States
- Employees
- MGRX N/A
- NURO N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- NURO Medical/Dental Instruments
- Sector
- MGRX Technology
- NURO Health Care
- Exchange
- MGRX Nasdaq
- NURO Nasdaq
- Market Cap
- MGRX 7.0M
- NURO 8.2M
- IPO Year
- MGRX 2023
- NURO N/A
- Fundamental
- Price
- MGRX $2.50
- NURO $4.42
- Analyst Decision
- MGRX
- NURO
- Analyst Count
- MGRX 0
- NURO 0
- Target Price
- MGRX N/A
- NURO N/A
- AVG Volume (30 Days)
- MGRX 1.0M
- NURO 14.4K
- Earning Date
- MGRX 10-29-2024
- NURO 11-01-2024
- Dividend Yield
- MGRX N/A
- NURO N/A
- EPS Growth
- MGRX N/A
- NURO N/A
- EPS
- MGRX N/A
- NURO N/A
- Revenue
- MGRX $866,792.00
- NURO $4,383,614.00
- Revenue This Year
- MGRX N/A
- NURO N/A
- Revenue Next Year
- MGRX N/A
- NURO N/A
- P/E Ratio
- MGRX N/A
- NURO N/A
- Revenue Growth
- MGRX 245.48
- NURO N/A
- 52 Week Low
- MGRX $2.15
- NURO $2.66
- 52 Week High
- MGRX $16.80
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- MGRX 32.69
- NURO 65.06
- Support Level
- MGRX $2.20
- NURO $3.96
- Resistance Level
- MGRX $2.83
- NURO $4.69
- Average True Range (ATR)
- MGRX 0.41
- NURO 0.22
- MACD
- MGRX -0.06
- NURO 0.04
- Stochastic Oscillator
- MGRX 8.44
- NURO 82.35
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.